All PlansCoverageLow impact
Multispectral Digital Skin Lesion Analysis
Blue Cross & Blue Shield of Mississippi·Dermatology·Medical Policy
Effective date
Aug 1, 2025
We identified it
Jun 20, 2026
Summary
This policy confirms that Multispectral Digital Skin Lesion Analysis (MSDSLA) remains considered investigational and not covered for evaluating pigmented skin lesions. The policy was reviewed with no changes to coverage determination, maintaining that claims using related codes will be denied as investigational.
Action Required
Continue to deny claims for CPT code 0061U (multispectral skin lesion analysis) as investigational. Ensure billing system maintains this code as non-covered and educate providers that this technology remains investigational with no coverage available.